Sustained benefits of avalglucosidase alfa in late-onset Pompe disease Presented ByDr Benedikt Schoser, Ludwig-Maximilians-University of Munich, Germany TrialNEO1; NEO-EXT ConferenceEAN 2020 TypePeer-reviewed article 10 September 2020 14:37